Insider Transactions in Q1 2025 at Maravai Lifesciences Holdings, Inc. (MRVI)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 31
2025
|
Kurt Oreshack General Counsel |
SELL
Open market or private sale
|
Direct |
25,000
-12.98%
|
$125,000
$5.03 P/Share
|
Jan 15
2025
|
Peter Michael Leddy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,042
-8.53%
|
$128,168
$4.56 P/Share
|
Jan 15
2025
|
Christine Dolan Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,704
-11.03%
|
$114,816
$4.56 P/Share
|
Jan 15
2025
|
Kurt Oreshack General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
31,438
-14.03%
|
$125,752
$4.56 P/Share
|
Jan 15
2025
|
Rebecca Buzzeo Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
45,456
-12.6%
|
$181,824
$4.56 P/Share
|
Jan 15
2025
|
Andrew Burch Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
54,412
-12.85%
|
$217,648
$4.56 P/Share
|
Jan 15
2025
|
Kevin Herde Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
46,344
-13.77%
|
$185,376
$4.56 P/Share
|
Jan 15
2025
|
William E. Martin Iii Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
160,981
-16.27%
|
$643,924
$4.56 P/Share
|